Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
STAT+
Biotech
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Startup targeting DNA repeats in Huntington’s and other diseases debuts with $59 million

By Jonathan Saltzman — Boston GlobeDec. 17, 2019

Reprints
Genome
Adobe

A Cambridge, Mass., biotech that hopes to develop treatments for devastating rare genetic disorders, including Huntington’s disease, was officially unveiled Tuesday after raising $59 million in venture capital.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Jonathan Saltzman — Boston Globe

Tags

Texas judge strikes down major Obamacare provision protecting preventive…
Texas judge strikes down major Obamacare provision protecting preventive care
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: Judge blocks required ACA coverage for preventive care;…
Pharmalittle: Judge blocks required ACA coverage for preventive care; Supreme Court urged to review skinny label…
3 keys to successful biopharma-academia drug development collaborations
3 keys to successful biopharma-academia drug development collaborations

Recommended Stories